Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelodysplastic syndrome (MDS)
Closed
Phase 2
This study is comparing 2 treatments for myelodysplastic syndromes to increase the number of .
Myelodysplastic syndromes (MDS) are a group of blood cancers. This group of conditions causes a drop in the number of blood cells.
This study is for people who:
have low risk MDS
can’t have a drug called ), it didn’t work or it has stopped working
have low
Recruitment start: 21 December 2021
Recruitment end: 30 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Stephen Jenkins
Professor Janet Dunn
Dr Manoj Raghavan
Blood Cancer UK
The Dudley Group NHS Foundation Trust
University of Warwick
The University of Birmingham
MDS UK Patient Support Group
You can see a map of where this study is taking place on the REPAIR-MDS trial website(link is external).
Last reviewed: 29 September 2024
CRUK internal database number: 19222
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
